IRIS
PISANI, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 75.273
EU - Europa 4.117
AS - Asia 1.358
Continente sconosciuto - Info sul continente non disponibili 28
SA - Sud America 26
OC - Oceania 10
AF - Africa 9
Totale 80.821
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 75.251
UA - Ucraina 1.038
IE - Irlanda 808
CN - Cina 730
DE - Germania 689
IT - Italia 454
KR - Corea 448
SE - Svezia 298
GB - Regno Unito 216
FI - Finlandia 207
FR - Francia 197
RU - Federazione Russa 93
JP - Giappone 39
IN - India 34
BE - Belgio 26
EU - Europa 26
PL - Polonia 25
NL - Olanda 22
CA - Canada 16
KG - Kirghizistan 16
TH - Thailandia 13
CH - Svizzera 11
CL - Cile 11
HK - Hong Kong 11
BR - Brasile 10
SG - Singapore 10
AU - Australia 8
IR - Iran 8
RO - Romania 8
VN - Vietnam 8
PT - Portogallo 6
DM - Dominica 5
DZ - Algeria 5
PH - Filippine 5
TR - Turchia 5
UZ - Uzbekistan 4
AL - Albania 3
BD - Bangladesh 3
DK - Danimarca 3
GR - Grecia 3
JO - Giordania 3
MY - Malesia 3
NG - Nigeria 3
NP - Nepal 3
A2 - ???statistics.table.value.countryCode.A2??? 2
ES - Italia 2
ID - Indonesia 2
KW - Kuwait 2
KZ - Kazakistan 2
LT - Lituania 2
NZ - Nuova Zelanda 2
PE - Perù 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AT - Austria 1
CO - Colombia 1
EC - Ecuador 1
GE - Georgia 1
IL - Israele 1
IQ - Iraq 1
KH - Cambogia 1
LK - Sri Lanka 1
MA - Marocco 1
MD - Moldavia 1
MT - Malta 1
MX - Messico 1
SI - Slovenia 1
TW - Taiwan 1
Totale 80.821
Salva come PNG Salva come JPEG
Città #
Woodbridge 22.872
Wilmington 20.329
Houston 18.802
Fairfield 2.674
Ann Arbor 1.796
Ashburn 1.218
Seattle 1.067
Chandler 1.005
Jacksonville 942
Cambridge 914
Dublin 751
Medford 547
Dearborn 365
Beijing 303
Lawrence 260
New York 207
Menlo Park 196
Rome 167
Zhengzhou 145
San Diego 97
Mülheim 82
Milan 60
Norwalk 47
Mountain View 45
University Park 45
Nanjing 44
Hefei 40
London 37
Falls Church 36
Verona 35
Redwood City 34
Shanghai 33
Detroit 30
Kunming 29
Mcallen 28
San Mateo 28
Saint Petersburg 26
Brussels 23
Palo Alto 23
Redmond 22
Kraków 20
Monmouth Junction 20
Guangzhou 19
Hangzhou 17
Seoul 16
Chicago 13
Nanchang 13
Engelhard 12
Bangkok 11
Incheon 11
Los Angeles 11
Toronto 11
Indiana 10
Helsinki 9
Phoenix 9
San Francisco 9
Shenyang 9
São Paulo 9
Council Bluffs 8
Hounslow 8
Boardman 7
Groningen 7
Kilburn 7
St. George 7
Tokyo 7
Dong Ket 6
Fuzhou 6
Philadelphia 6
Bouïra 5
Chengdu 5
Chiswick 5
Del Norte 5
Nürnberg 5
Roseau 5
Simi Valley 5
Wuhan 5
Acton 4
Auburn Hills 4
Bangalore 4
Chongqing 4
Clearwater 4
Florence 4
Hong Kong 4
Jinan 4
La Veta 4
Lappeenranta 4
Louisville 4
Mumbai 4
Pune 4
Santarém 4
Shaoxing 4
Taiyuan 4
Center 3
Changsha 3
Dallas 3
Dover 3
Frankfurt am Main 3
Kathmandu 3
Knoxville 3
Manila 3
Totale 75.830
Salva come PNG Salva come JPEG
Nome #
Early synaptic dysfunction in Parkinson's disease: Insights from animal models 441
Aberrant striatal synaptic plasticity in monogenic parkinsonisms 432
Optogenetic stimulation reveals distinct modulatory properties of thalamostriatal vs corticostriatal glutamatergic inputs to fast-spiking interneurons 432
Subtle alterations of excitatory transmission are linked to presynaptic changes in the hippocampus of PINK1-deficient mice 430
Loss of muscarinic autoreceptor function impairs long-term depression but not long-term potentiation in the striatum 429
Regional specificity of synaptic plasticity deficits in a knock-in mouse model of DYT1 dystonia 427
Actions of glycine on non-dopaminergic neurons of the rat substantia nigra 427
Muscarinic IPSPs in rat striatal cholinergic interneurones 426
Homeostatic changes of the endocannabinoid system in Parkinson's disease. 426
Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. I. Modulation of corticostriatal synaptic transmission 424
Hypoglycemia, hypoxia, and ischemia in a corticostriatal slice preparation: electrophysiologic changes and ascorbyl radical formation 421
High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patients 417
Anticholinergic drugs rescue synaptic plasticity in DYT1 dystonia: Role of M1 muscarinic receptors 417
Age-related functional changes of high-voltage-activated calcium channels in different neuronal subtypes of mouse striatum 415
Neuronal vulnerability following inhibition of mitochondrial complex II: a possibile ionic mechanism for Huntington’s disease. 414
Occurrence of Writing Tremor in Patients With Scans Without Evidence of Dopaminergic Deficit 413
Striatal synaptic plasticity: implications for motor learning and Parkinson's disease 411
Abnormal plasticity in dystonia: Disruption of synaptic homeostasis 411
Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson's disease 409
Activation of dopamine D1-like receptors excites LTS interneurons of the striatum 408
The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease 407
Inhibition of persistent sodium current fraction and voltage-gated L-type calcium current by propofol in cortical neurons: Implications for its antiepileptic activity 406
Synaptic transmission in the striatum: from plasticity to neurodegeneration 406
Metabotropic glutamate receptors and striatal synaptic plasticity: implications for neurological diseases 406
Activation of group III metabotropic glutamate receptors depresses glutamatergic transmission at corticostriatal synapse 405
Early abnormalities in 123I-ioflupane (DaTSCAN) imaging in the fragile X-associated tremor ataxia syndrome (FXTAS): a case report 405
Strength and weaknesses of cerebrospinal fluid biomarkers in Alzheimer's disease and possible detection of overlaps with frailty process 404
Biochemical and electrophysiological changes of substantia nigra pars reticulata driven by subthalamic stimulation in patients with Parkinson's disease 404
Rhes regulates dopamine D2 receptor transmission in striatal cholinergic interneurons 404
Distinct roles of group I mGlu receptors in striatal function 403
Re-emergence of striatal cholinergic interneurons in movement disorders 402
Developmental profile of the aberrant dopamine D2 receptor response in striatal cholinergic interneurons in DYT1 dystonia 399
Electrophysiological recordings and calcium measurements in striatal large aspiny interneurons in response to combined O2/glucose deprivation 395
Striatal spiny neurons and cholinergic interneurons express differential ionotropic glutamatergic responses and vulnerability: implications for ischemia and Huntington's disease 395
Role of Ca2+ in striatal LTD and LTP 395
Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial parkinsonism-linked gene DJ-1 394
Opposite membrane potential changes induced by glucose deprivation in striatal spiny neurons and in large aspiny interneurons 394
null 393
Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine 393
Long-term synaptic depression in the striatum: physiological and pharmacological characterization 393
Putaminal, but not nigral alterations, characterize hemiparkinsonism-hemiatrophy syndrome: a case report 391
Morphological and functional study of dwarf neurons in the rat striatum 391
A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression 390
Endogenous ACh enhances striatal NMDA-responses via M1-like muscarinic receptors and PKC activation 390
Striatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystonia 390
Seletracetam (ucb 44212) inhibits high-voltage-activated Ca2+ currents and intracellular Ca2+ increase in rat cortical neurons in vitro 390
Involvement of intracellular calcium stores during oxygen/glucose deprivation in striatal large aspiny interneurons 389
Behavioural learning-induced increase in spontaneous GABAA-dependent synaptic activity in rat striatal cholinergic interneurons 389
Mild cerebello-thalamo-cortical impairment in patients with normal dopaminergic scans (SWEDD) 389
Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine 388
Plastic and behavioral abnormalities in experimental Huntington's disease: a crucial role for cholinergic interneurons 388
Cocaine and amphetamine depress striatal GABAergic synaptic transmission through D2 dopamine receptors 387
Antiepileptic drugs on calcium currents recorded from cortical and PAG neurons: therapeutic implications for migraine 387
Persistent chorea in DYT6, due to anticholinergic therapy 387
Ionic mechanisms underlying differential vulnerability to ischemia in striatal neurons 386
Frontal assessment battery scores and non-motor symptoms in parkinsonian disorders 386
Receptor subtypes involved in the presynaptic and postsynaptic actions of dopamine on striatal interneurons 385
Early ionic and membrane potential changes caused by the pesticide rotenone in striatal cholinergic interneurons 385
Effects of two weeks of cerebellar theta burst stimulation in cervical dystonia patients 385
Intracellular calcium increase in epileptiform activity: modulation by levetiracetam and lamotrigine 385
SYNAPTIC PLASTICITY IN THE STRIATUM - ROLE OF GLUTAMATE AND DOPAMINE-RECEPTORS 385
Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors 384
Dopamine, acetylcholine and nitric oxide systems interact to induce corticostriatal synaptic plasticity 384
Electrophysiology of dopamine D-1 receptors in the basal ganglia: old facts and new perspectives 384
Transmitter release associated with long-term synaptic depression in rat corticostriatal slices 384
Blockade of M2-like muscarinic receptors enhances long-term potentiation at corticostriatal synapses 383
Distinct roles of D1 and D5 dopamine receptors in motor activity and striatal synaptic plasticity 383
Post-ischaemic long-term synaptic potentiation in the striatum: a putative mechanism for cell type-specific vulnerability 382
Altered profile and D2-dopamine receptor modulation of high voltage-activated calcium current in striatal medium spiny neurons from animal models of Parkinson's disease. 382
Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. II. Modulation of high-voltage-activated calcium currents 382
Vulnerability of medium spiny striatal neurons to glutamate: role of Na+/K+ ATPase 381
Striatal metabotropic glutamate receptor function following experimental parkinsonism and chronic levodopa treatment 380
Synaptic plasticity in the ischaemic brain 380
Pisa syndrome in Parkinson disease: An observational multicenter Italian study 380
Selective Inactivation of Striatal FosB/ΔFosB-Expressing Neurons Alleviates L-Dopa-Induced Dyskinesia 379
Hyperkinetic disorders and loss of synaptic downscaling 378
Engineering animal models of dystonia 376
A field potential analysis on the effects of lamotrigine, GP 47779, and felbamate in neocortical slices 376
New genetic insights highlight 'old' ideas on motor dysfunction in dystonia 376
Enhanced sensitivity to group II mGlu receptor activation at corticostriatal synapses in mice lacking the familial parkinsonism-linked genes PINK1 or Parkin 376
Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia. 376
Towards a new era for dystonia, a high priority for biomedical research 375
Acetyl-L-carnitine protects striatal neurons against in vitro ischemia: the role of endogenous acetylcholine 375
Cerebellar synaptogenesis is compromised in mouse models of DYT1 dystonia 375
Dopamine-dependent CB1 receptor dysfunction at corticostriatal synapses in homozygous PINK1 knockout mice 375
Tissue plasminogen activator is required for corticostriatal long-term potentiation 374
Metabotropic glutamate 2 receptors modulate synaptic inputs and calcium signals in striatal cholinergic interneurons 374
The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia 374
The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life 374
Outward potassium currents activated by depolarization in rat globus pallidus 374
A clinical and biochemical analysis in the differential diagnosis of idiopathic normal pressure hydrocephalus 374
The Italian Dystonia Registry: rationale, design and preliminary findings 374
Role of tonically-active neurons in the control of striatal function: cellular mechanisms and behavioral correlates 372
Long-term Potentiation in the Striatum is Unmasked by Removing the Voltage-dependent Magnesium Block of NMDA Receptor Channels 371
Activation of metabotropic glutamate receptors inhibits calcium currents and GABA-mediated synaptic potentials in striatal neurons 370
Heidenhain variant in two patients with inherited V210I Creutzfeldt-Jakob disease 370
Enhanced sensitivity of DJ-1-deficient dopaminergic neurons to energy metabolism impairment: role of Na+/K+ ATPase 369
Chronic cocaine prevents depotentiation at corticostriatal synapses 368
NR2B subunit exerts a critical role in postischemic synaptic plasticity 367
Targeting striatal cholinergic interneurons in Parkinson's disease: focus on metabotropic glutamate receptors 367
Totale 39.254
Salva come PNG Salva come JPEG
Categoria #
all - tutte 139.060
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 139.060
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20196.575 0 0 0 0 0 0 0 0 0 1.967 2.287 2.321
2019/202023.660 1.937 2.130 1.742 2.258 1.950 2.482 2.025 2.162 2.094 1.780 1.428 1.672
2020/202112.736 1.413 1.690 1.399 1.628 1.314 1.281 1.558 1.227 306 275 492 153
2021/20222.632 112 215 127 148 39 280 252 114 152 294 148 751
2022/20232.836 365 221 79 316 202 765 264 151 228 6 167 72
2023/2024813 124 34 67 21 89 240 41 110 66 21 0 0
Totale 81.601